Swiss authorities grant product approval for Intercell's IXIARO
Vaccine to help prevent Japanese Encephalitis now available in Switzerland
15-Jul-2010 -
Intercell AG announced that Swissmedic has approved IXIARO®,its vaccine against Japanese Encephalitis. IXIARO®, which is distributed and marketed by Novartis, is now available in Switzerland.
The decision by the Swiss authorities represents another important milestone for the licensure process ...
Intercell
Japanese encephalitis
Novartis
+2